Brief: Giant Biogene Posts HY Adjusted Net Profit (Non-IFRS Measure) Of RMB676.4 Mln
28/08/2023 11:24
Aug 28 (Reuters) - Giant Biogene Holding Co Ltd
2367.HK :
* ADJUSTED NET PROFIT FOR SIX MONTHS (NON-IFRS MEASURE)
RMB676.4
MILLION VERSUS RMB463.1 MILLION
* HY REVENUE RMB1.61 BILLION VERSUS RMB984.9 MILLION
Further company coverage: 2367.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan